At the Lift Cannabis Expo in Vancouver held from January 12-14, the Investing News Network (INN) had the opportunity to catch up with a range of industry and thought leaders from the cannabis business world.
In an exclusive interview with INN, David Argudo, CEO of High Hampton Holdings (CSE:HC) talked about the latest obstacles in the newly opened recreational market in California. Argudo also talks about the need for more research to support the claims on the potential for medical cannabis.
Argudo explained how his background in medical research has helped the company stay ahead and what they try to do differently from their competitors in similar situations. High Hampton shares trade on the Canadian Securities Exchange but their focus is on the market in California and for now, only the medical one.
“Our business strategy is to derisk the level that is associated in participating in California and especially in the States where you have federal uncertainties,” Argudo told INN. Cannabis is an illegal drug in the US under the under the Controlled Substance Act at the federal level. However, eight states now allowed the recreational use of cannabis.
Listen to our interview with Argudo at the Lift Cannabis Expo for more of what he had to say.
Don’t forget to follow us @INN_Cannabis for real-time news updates!Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the article. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.Editorial Disclosure: High Hampton Holdings is a client of the Investing News Network. This article is not paid-for content.
